COVID-19 surveillance (as of 2 April 2024)


coronavirus genomes were sequenced by the Sanger Institute


Sanger staff contributed to the 7-days-per-week operation


coronavirus genomes sequenced around the globe (GISAID)

How COVID-19 surveillance works

Sanger Seminar: Comprehensive genomic surveillance of SARS-CoV-2 in the UK

Seminar: How we read SARS-CoV-2 genomes, and how these data are used by the COG-UK Consortium to track the spread of the virus, and identify new variants; including B.1.1.7.

Q&A session with Dr Jeff Barrett, Director the Wellcome Sanger Institute COVID-19 Genomics Initiative.

Human Cell Atlas COVID-19 research

As part of our work in the Human Cell Atlas initiative, our research teams explored how the SARS-CoV-2 virus enters people’s cells and cause symptoms.

To find out more, please visit:

Latest COVID-19 News and Blogs